Single User License
INR 199976
Site License
INR 399952
Corporate User License
INR 599928

Service Tax Additional

select a format

Single User License
USD 2995
Site License
USD 5990
Corporate User License
USD 8985


Request a quote
Request a Customized research
Request for Sample Report

Recent Viewed Reports

Why Ken Reasearch?


While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"

Ken Research completed the report successfully with tough deadline and large requirement. Really appreciate it... "Sales Manager, Largest India Aesthetic Laser Manufacturer"

We found the report really useful in understanding the complex Indian market and it provided lots of high quality insights. On the basis of this we commissioned Ken to produce a bespoke follow up to answer some specific questions about our market. This is now being used to help develop our marketing and sales strategy. We were very pleased with the comprehensive coverage, detail provided and actionable insights.... "Owner, Therefore Consulting UK"

Glaucoma-Current and Future Players

Glaucoma-Current and Future Players

  Request for Sample Report

Executive Summary

Glaucoma-Current and Future Players


GlobalData has released its pharma report, "Glaucoma-Current and Future Players". The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing Glaucoma Market. The report identifies and analyses the key companies shaping and driving the global Glaucoma market. The report provides insight into the competitive Glaucoma landscape, including new companies entering the market. This report is built using data and information sourced from proprietary databases, primary and secondary and in-house analysis by GlobalData's team of industry experts.

*This is an on-demand report and will be delivered within 24 hrs. (excluding weekends) of the purchase.


Investigation of current and future market competition for Glaucoma

Competitor assessment

Coverage of key market players and company profiles including business description, financial overview and SWOT analysis.

Strategic assessment of Glaucoma sector through market impact analysis, future market scenario and company analysis

Reasons To Buy

Gain a high level view of the trends shaping and driving Glaucoma market

Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition.

Create an effective counter-strategy to gain a competitive advantage against those currently in the market

What's the next big thing in the global Glaucoma market landscape? Identify, understand and capitalize

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 4

1.2 List of Figures 4

2 Introduction 5

2.1 Catalyst 5

2.2 Related Reports 5

3 Market Outlook 7

3.1 Global Markets 7

3.1.1 Forecast 7

3.1.2 Drivers and Barriers-Global Issues 13

4 Current and Future Players 14

4.1 Overview 14

4.2 Trends in Corporate Strategy 16

4.3 Company Profiles 17

4.3.1 Pfizer 17

4.3.2 Alcon 18

4.3.3 Allergan 20

4.3.4 Santen 21

4.3.5 Aerie Pharmaceuticals 23

4.3.6 Inotek Pharmaceuticals 25

4.3.7 Bausch & Lomb 26

4.3.8 Kowa Company 27

4.3.9 Otsuka Pharmaceutical 28

5 Appendix 30

5.1 Bibliography 30

5.2 Abbreviations 71

5.3 Methodology 76

5.4 Forecasting Methodology 76

5.4.1 Percent Drug-Treated Patients 76

5.4.2 Drugs Included in Each Therapeutic Class 77

5.4.3 Launch and Patent Expiry Dates 78

5.4.4 General Pricing Assumptions 78

5.4.5 Individual Drug Assumptions 79

5.4.6 Pricing of Pipeline Agents 88

5.5 Primary Research-KOLs Interviewed for this Report 89

5.6 Primary Research-High-prescriber Survey 91

5.7 About the Authors 92

5.7.1 Analyst 92

5.7.2 Therapy Area Director 92

5.7.3 Epidemiologist 93

5.7.4 Global Head of Healthcare 93

5.8 About GlobalData 94

5.9 Disclaimer 94

1.2 List of Figures

Figure 1: Global Sales for Glaucoma by Region, 2013-2023 10

Figure 2: Drug Sales by Class for Glaucoma, 2013 and 2023 11

Figure 3: Global Drug Sales by Class for Glaucoma, 2013-2023 12

Figure 4: Global Sales of Branded Products for Glaucoma by Company, 2013-2023 15

Figure 5: Company Portfolio Gap Analysis in Glaucoma, 2013-2023 16

1.1 List of Tables

Table 1: Global Sales Forecast (USD m) for Glaucoma, 2013-2023 9

Table 2: Glaucoma Market-Drivers and Barriers, 2013-2023 13

Table 3: Key Companies in the Glaucoma Market in the 7MM, 2014 14

Table 4: Pfizer's Glaucoma Portfolio Assessment, 2014 18

Table 5: Alcon's Glaucoma Portfolio Assessment, 2014 19

Table 6: Allergan's Glaucoma Portfolio Assessment, 2014 21

Table 7: Santen's Glaucoma Portfolio Assessment, 2014 23

Table 8: Aerie's Glaucoma Portfolio Assessment, 2014 24

Table 9: Inotek's Glaucoma Portfolio Assessment, 2014 26

Table 10: Baush & Lomb/Valeant's Glaucoma Portfolio Assessment, 2014 27

Table 11: Kowa's Glaucoma Portfolio Assessment, 2014 28

Table 12: Otsuka's Glaucoma Portfolio Assessment, 2014 29

Table 13: Key Launch Dates 78

Table 14: Key Patent Expiries 78

Table 15: Surveyed High-Prescribing Physicians (Non-KOLs), by Country 91

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@]





Aerie Pharmaceuticals

Inotek Pharmaceuticals

Bausch & Lomb

Kowa Company

Otsuka Pharmaceutical

Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204


Company Brochure

Engage with Us

query [@]